𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mycophenolate mofetil monotherapy in stable liver transplant recipients with progressive renal failure

✍ Scribed by O. Detry; A. De Roover; P. Honoré; J. Delwaide; N. Jacquet; M. Meurisse

Book ID
117231846
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
55 KB
Volume
34
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mycophenolate mofetil monotherapy in liv
Mycophenolate mofetil monotherapy in liver transplant recipients: A single center experience
✍ Kyrsten D. Fairbanks; Paul J. Thuluvath 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

The long-term use of calcineurin inhibitors (CIs) is associated with significant morbidity in liver transplant recipients. Although mycophenolate mofetil (MMF) is well tolerated, two small studies reported an unacceptable rate of acute allograft rejection in liver transplant recipients receiving MMF

Pharmacokinetics of mycophenolate mofeti
Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine
✍ Steven J. Lobritto; Philip Rosenthal; Rene Bouw; Mimi Leung; Paul Snell; Richard 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

There are few pharmacokinetic data for mycophenolate mofetil (MMF) when used in combination with cyclosporine (CsA) in pediatric liver transplant recipients. The aim of this study was to assess the pharmacokinetics of MMF in stable pediatric liver transplant patients and estimate the dose of MMF req